Orchid Pharma Q3 Results
- BSE: 524372
- NSE: ORCHPHARMA
- ISIN: INE191A01027
- Sector: Biotechnology & Drugs
BSE
702.95
21.55 (3.16%)
21.55 (3.16%)Volume2.11 K
Updated: Fri 8 May, 2026 | 15:29:07
NSE
703.4521.40 (3.14%)
21.40 (3.14%)Volume88.81 K
Updated: Fri 8 May, 2026 | 15:50:46
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
- Total Income₹207.27 Cr.(-4.64%)
- Operating Profit₹-14.58 Cr.(NA%)
- Profit After Tax₹-12.61 Cr.(NA%)
- Operating Margin-7.03%(NA%)
Note: Comparison is on YoY basis
Quarterly - Orchid Pharma Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 221.85 | 200.99 | 8.80% | 194.47 | 11.15% |
| Depreciation/ Amortization | 9.03 | 8.63 | 1.44% | 9.27 | 4.93% |
| Operating Income | -14.58 | 21.71 | 40.48% | 26.12 | 0.00% |
| Net Income | -12.61 | 27.24 | 120.38% | 29.43 | 0.00% |
| Other Operating Expenses Total | 38.43 | 41.14 | 2.09% | 44.12 | -12.92% |
| Net Income Before Taxes | -12.15 | 25.90 | 264.22% | 30.19 | 0.00% |
| Total Revenue | 207.27 | 222.70 | 7.10% | 220.59 | -4.64% |
| Selling/ General/ Admin Expenses Total | 24.13 | 20.06 | -2.91% | 19.14 | 9.38% |
| Diluted Normalized EPS | -1.09 | 5.37 | -3.90% | 6.18 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.